Joyce O’Shaughnessy

1. Pembrolizumab for Early Triple-Negative Breast Cancer
   2020/02/26 by Peter Schmid, Javier Cortés, Lajos Pusztai +18 · 18 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #Cancer Immunotherapy and Biomarkers #Cancer Research and Treatments
2. Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis
   2020/09/14 by Min Huang, Joyce O'Shaughnessy, Joyce O’Shaughnessy +17 · 26 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #HER2/EGFR in Cancer Research #Cancer Genomics and Diagnostics
3. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
   2021/07/01 by David Miles, Fabrice André, F. André +242 · 3 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Advanced Breast Cancer Therapies #Breast Cancer Treatment Studies #Cancer Immunotherapy and Biomarkers